Who May Qualify for Semaglutide? Eligibility Requirements

The Basic Qualification Criteria

Let's cut straight to it. The FDA-approved guidelines for semaglutide (marketed as Wegovy for weight loss) specify eligibility based on these primary factors:

Understanding the BMI Requirements

BMI (Body Mass Index) is the primary metric used, though it's not perfect. Here's how it breaks down:

• BMI 25-26.9: may not meet standard labeled weight-management criteria without additional context
• BMI 27-29.9: Eligible with weight-related comorbidities
• BMI 30-34.9: often meets the labeled starting threshold for obesity treatment
• BMI 35-39.9: usually meets the obesity threshold, but the full medical picture still matters
• BMI 40+: often strengthens the medical case, especially when weight-related conditions are present

BMI is only one screening tool. Providers also look at medical history, current medications, weight-related conditions, and whether the treatment is safe and appropriate for the individual patient.

Weight-Related Health Conditions That Matter

If your BMI is 27-29.9, you'll need at least one of these conditions to qualify:

Who Should NOT Take Semaglutide

Just as important as knowing who qualifies is understanding who doesn't. These are contraindications—situations where semaglutide should not be used:

Special Considerations and Gray Areas

Some situations require extra discussion with your healthcare provider:

If You Have Type 1 Diabetes

Semaglutide is not approved for type 1 diabetes. If a person with type 1 diabetes is asking about weight-management use, that discussion should involve specialist oversight rather than assumptions based on standard type 2 or obesity-treatment guidance.

If You're Over 65

Age alone isn't a disqualifier, but older adults may need closer monitoring. Kidney function, medication interactions, and overall health status become more important considerations.

If You Have Kidney Disease

Semaglutide can be used with mild to moderate kidney disease, but severe kidney impairment requires careful evaluation. Your healthcare provider will need recent kidney function tests.

If You're Taking Other Medications

Semaglutide slows stomach emptying, which can affect absorption of other medications, especially:

• Oral diabetes medications or regimens that already raise hypoglycemia risk
• Blood thinners like warfarin
• Medications where timing or predictable absorption is especially important
• Any treatment the prescribing clinician specifically flags for closer review

The Consultation Process: What to Expect

When you consult with a healthcare provider about semaglutide, here's what they'll typically assess:

Insurance Coverage vs. Cash Pay

Here's where things get tricky. You might medically qualify but face coverage issues:

Insurance Coverage Requirements

Most insurance plans have additional requirements beyond FDA criteria:

• Failed attempts at weight loss with diet and exercise (documented)
• BMI thresholds may be higher (sometimes requiring 35+ even without comorbidities)
• Specific comorbidity requirements may be more stringent
• Prior authorization required (can take weeks)
• Step therapy (trying cheaper medications first)

Cash Pay Options

If insurance doesn't cover it or you don't want to navigate the approval process, cash-pay options exist:

• Compounded-access routes: should be evaluated for legitimacy, pharmacy type, and current pricing rather than assumed to be the best fallback
• Brand-name cash pay: verify current manufacturer or pharmacy pricing directly because terms change over time
• Patient assistance programs: may be available depending on eligibility and current program rules

Online Prescriptions: Are They Legitimate?

Yes, online healthcare providers can legally prescribe semaglutide IF they follow proper protocols:

• Licensed healthcare provider in your state
• Proper medical evaluation (not just a questionnaire)
• Ongoing monitoring and follow-up
• Medication from licensed pharmacies

What If You Don't Qualify?

If semaglutide isn't right for you, alternatives exist:

• Tirzepatide: Similar mechanism, different eligibility criteria
• Other GLP-1 agonists: Liraglutide (Saxenda) has different dosing
• Non-GLP-1 options: Phentermine, naltrexone-bupropion, orlistat
• Lifestyle interventions: Medical nutrition therapy, supervised exercise programs
• Bariatric surgery: For those who qualify and haven't succeeded with medications

The Bottom Line on Eligibility

Many adults with a BMI of 30 or higher, or a BMI of 27 or higher plus a relevant weight-related condition, may qualify for semaglutide evaluation. The key is working with a legitimate healthcare provider who can assess whether the treatment fits your medical history, current risks, and treatment goals.

Don't self-diagnose or self-prescribe. A proper medical evaluation ensures semaglutide is safe and appropriate for your specific circumstances.